$49.5
$69.3
Description Include: 37 videos 37 file sub vtt 30 pdfs, size: 5.48 GB Target Audience: gastroenterologists, GI surgeons, internists, and residents Information: Friday, November 7, 2025, 8:00 AM – Saturday, November 8, 2025, 5:00 PM, Sofitel Philadelphia Hotel, Philadelphia, PA The 14th University of Pennsylvania Inflammatory Bowel Disease Symposium will highlight the advances in the treatment of IBD. Lectures by nationally and internationally recognized experts will be followed by interactive case presentations and panel discussions. A wide array of topics will be discussed including pharmacologic therapies and surgical interventions and optimal use of imaging and endoscopy. Participants will receive a comprehensive overview of the latest available research and clinical information on evaluation and management of patients with IBD. Specialties – FAMILY MEDICINE, INTERNAL MEDICINE, INTERNAL MEDICINE – Gastroenterology, SURGERY Learning Objectives After completing this activity, participants should be able to: Describe how to appropriately prescribe biologics and other targeted therapies for IBD Determine the proper utilization of biomarkers and therapeutic drug monitoring to improve outcomes Discuss goals of treatment and how to use medication, surgery and ancillary strategies to achieve these goals Explain how to successfully manage complications of IBD such as perianal fistula, stricture, and abscess Topics: FRIDAY, NOVEMBER 7, 2025 7:15 AM – 8:00 AM Registration & Continental Breakfast 7:45 AM – 8:00 AM Virtual Attendee Sign-in (Broadcast goes live at 8:00 am) 8:00 AM – 8:10 AM Introduction Gary Lichtenstein, MD SESSION 1 PATHOPHYSIOLOGY AND EPIDEMIOLOGY OF IBD Moderator: James D. Lewis, MD, MSCE 8:10 AM – 8:30 AM Clinical Relevance of Microbiome and Metabolome Gary D. Wu, MD 8:30 AM – 8:50 AM Immune System Targets Relevant to IBD Therapeutics Nicole M. Belle, MD, PhD 8:50 AM – 9:10 AM Environmental Exposures and Risk of IBD Ashwin Ananthakrishnan, MBBS, MPH 9:10 AM – 9:30 AM Case Presentation: C. Diff, FMT/SIBO Maura Levandowski, AGACNP-BC 9:30 AM – 9:50 AM Panel Discussion Moderator: James D. Lewis, MD, MSCE Session I Faculty 9:50 AM – 10:10 AM Break SESSION II MEDICAL THERAPIES – PART 1 Moderator: Gary Lichtenstein, MD 10:10 AM – 10:30 AM Indications and Optimal use of Mesalamine, Steroids and Immunomodulators Shivali Berera, MD 10:30 AM – 10:50 AM Anti-TNFs and Biosimilars Andrew T. Weber, MD 10:50 AM – 11:10 AM Antitrafficking Agents: Vedolizumab, Ozanimod, Etrasimod Neilanjan Nandi, MD, FACG, AGAF, FACP 11:10 AM – 11:30 AM IL-23 Inhibitors in a New Era Gary Lichtenstein, MD 11:30 AM – 11:50 AM JAK’s be Nimble Meenakshi Bewtra, MD, PhD, MPH 11:50 AM – 12:10 PM Role of Supplements and Complementary Therapy for IBD Ashwin Ananthakrishnan, MBBS, MPH 12:10 PM – 12:30 PM Panel Discussion Moderator: Gary Lichtenstein, MD Session II Faculty 12:30 PM – 1:20 PM Lunch SESSION III UNIQUE CLINICAL SCENARIOS Moderator: Faten N. Aberra, MD, MSCE 1:20 PM – 1:40 PM Obesity and IBD Octavia Pickett-Blakely, MD, MHS 1:40 PM – 2:00 PM Managing the Pregnant Patient with IBD Farzana Rashid, MD 2:00 PM – 2:20 PM My Patient has Cancer, What Now? Aline J. Charabaty Pishvaian, MD 2:20 PM – 2:40 PM Clinicians Guide to Persistent Diarrhea, Urgency, Incontinence and Fatigue in IBD Russell D. Cohen, MD 2:40 PM – 3:00 PM Case Presentation: IBD with Anemia Andrew T. Weber, MD 3:00 PM – 3:20 PM Panel Discussion Moderator: Faten N. Aberra, MD, MSCE Session III Faculty 3:20 PM – 3:40 PM Break SESSION IV MEDICAL THERAPIES – PART 2 Moderator: Neilanjan Nandi, MD 3:40 PM – 4:00 PM Current and Future Use of Combination Therapies Faten N. Aberra, MD, MSCE 4:00 PM – 4:20 PM Comparative Effectiveness of Current Therapies for IBD James D. Lewis, MD, MSCE 4:20 PM – 4:40 PM Mild Crohn’s Disease Alexandra H. Weiss, MD 4:40 PM – 5:00 PM Acute Severe UC Nabeel Khan, MD 5:00 PM – 5:20 PM Panel Discussion Moderator: Neilanjan Nandi, MD Session IV Faculty 5:20 PM Closing Comments & Adjourn SATURDAY, NOVEMBER 8, 2025 7:30 AM – 8:00 AM Registration & Continental Breakfast 7:45 AM – 8:00 AM Virtual Attendee Sign-in (Broadcast goes live at 8:00 AM) 8:00 AM – 8:10 AM Day Two Welcome Remarks James D. Lewis, MD, MSCE SESSION V INTERDISCIPLINARY IBD CARE Moderator: Meenakshi Bewtra, MD, PhD, MPH 8:10 AM – 8:30 AM Dysplasia Guidelines and Management of Visible Polypoid and Non-Polypoid Dysplastic Lesions Anna Buchner, MD, PhD 8:30 AM – 8:50 AM Management of Perianal Crohn’s Aline J. Charabaty Pishvaian, MD 8:50 AM – 9:10 AM Update on IBD Surgery Erica Pettke, MD, MPH, FACS 9:10 AM – 9:30 AM Peri and Post-Operative Management of Crohn’s Disease Bo Shen, MD 9:30 AM – 9:50 AM Management of Pouch-related Disorders Bo Shen, MD 9:50 AM – 10:10 AM Case Presentation: Crohn’s with Intra-abdominal Abscess Shelby Leigh Weiss, FNP-BC 10:10 AM – 10:30 AM Panel Discussion Moderator: Meenakshi Bewtra, MD, PhD, MPH Session V Faculty 10:30 AM – 10:50 AM Break SESSION VI IBD OF THE FUTURE-DIAGNOSTICS AND TREATMENTS Moderator: Gary R. Lichtenstein, MD 10:50 AM – 11:10 AM Colonoscopy, CTE, MRE or Intestinal US – When and for Whom? Russell D. Cohen, MD 11:10 AM – 11:30 AM Evolution of Therapeutic Drug Monitoring and Biomarkers Chung Sang Tse, MD 11:30 AM – 11:50 AM What do I do When Everything Seems to Have Failed? Stephen B. Hanauer, MD 11:50 AM – 12:10 PM What to Expect in the Next Decade of IBD Care Stephen B. Hanauer, MD 12:10 PM – 12:30 PM Case Presentation: Potpourri of Challenging Clinical Decisions Robert Stein, MD 12:30 PM – 12:50 PM Panel Discussion Moderator: Gary R. Lichtenstein, MD Session VI Faculty 12:50 PM – 1:00 PM Closing Comments Gary R. Lichtenstein, MD 1:00 PM Adjourn
Git
